Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 34,869 |
| Other current assets | 623 |
| TOTAL | $35,492 |
| Non-Current Assets | |
| PPE Net | 17 |
| Other Non-Current Assets | 1,760 |
| TOTAL | $1,777 |
| Total Assets | $37,275 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,420 |
| Accrued Expenses | 2,960 |
| Other current liabilities | 880 |
| TOTAL | $5,274 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $5,274 |
| Shareholders' Equity | |
| Common Shares | 10 |
| Retained earnings | -50,671 |
| Other shareholders' equity | 40,002 |
| TOTAL | $32,001 |
| Total Liabilities And Equity | $37,275 |